Organigram Invests In Phylos Bioscience To Commercialize THCV And Scale Seed Based Production
Portfolio Pulse from Vuk Zdinjak
Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI) has entered into an agreement with Phylos Bioscience Inc. to initiate a technical and commercial relationship in Canada. The partnership aims to support Organigram's cultivation efforts with patent-pending technologies and genetics. Organigram plans to export THCV products to select legal international markets in the future.
May 26, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Organigram's partnership with Phylos Bioscience will support its cultivation efforts and potentially expand its market reach with THCV products.
The partnership with Phylos Bioscience will provide Organigram with access to patent-pending technologies and genetics, supporting its cultivation efforts in Canada. Additionally, the company plans to export THCV products to select legal international markets in the future, potentially expanding its market reach and increasing revenues.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100